Variations inPROKR2, But NotPROK2, Are Associated With Hypopituitarism and Septo-optic Dysplasia
Author(s) -
Mark J. McCabe,
Carles GastonMassuet,
Louise Gregory,
Kyriaki S. Alatzoglou,
Vaitsa Tziaferi,
Oualid Sbai,
Philippe Rondard,
Kohhei Masumoto,
Mamoru Nagano,
Yasufumi Shigeyoshi,
Marija Pfeifer,
Tony Hulse,
Charles Buchanan,
Nelly Pitteloud,
Juan Pedro Martı́nez-Barberá,
Mehul Dattani
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-3067
Subject(s) - kallmann syndrome , anosmia , medicine , compound heterozygosity , endocrinology , hypopituitarism , phenotype , genotype , genetics , biology , gene , disease , covid-19 , infectious disease (medical specialty)
Loss-of-function mutations in PROK2 and PROKR2 have been implicated in Kallmann syndrome (KS), characterized by hypogonadotropic hypogonadism and anosmia. Recent data suggest overlapping phenotypes/genotypes between KS and congenital hypopituitarism (CH), including septo-optic dysplasia (SOD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom